News
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
1d
Discover Magazine on MSNFDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results